Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | trypanothione reductase, putative | 0.055 | 1 | 1 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0182 | 0.2626 | 0.9238 |
Echinococcus granulosus | 5'partial|cyclin dependent kinase 1 | 0.0182 | 0.2626 | 0.2626 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.019 | 0.2803 | 0.2803 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.019 | 0.2803 | 0.2803 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.014 | 0.179 | 0.179 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.0213 | 0.0213 |
Trypanosoma brucei | trypanothione reductase | 0.055 | 1 | 1 |
Trichomonas vaginalis | glutathione reductase, putative | 0.019 | 0.2803 | 0.9863 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.019 | 0.2803 | 0.2803 |
Toxoplasma gondii | thioredoxin reductase | 0.055 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.019 | 0.2803 | 0.2803 |
Entamoeba histolytica | protein kinase , putative | 0.0192 | 0.2842 | 1 |
Entamoeba histolytica | protein kinase, putative | 0.0192 | 0.2842 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.019 | 0.2803 | 0.2803 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0182 | 0.2626 | 0.2626 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.019 | 0.2803 | 1 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.019 | 0.2803 | 0.2803 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.019 | 0.2803 | 0.2803 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0061 | 0.0213 | 0.0213 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0182 | 0.2626 | 0.2626 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0182 | 0.2626 | 0.9238 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.019 | 0.2803 | 0.2803 |
Schistosoma mansoni | protein kinase | 0.0192 | 0.2842 | 0.2842 |
Echinococcus granulosus | serine:threonine protein kinase 12 B | 0.0192 | 0.2842 | 0.2842 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.055 | 1 | 1 |
Loa Loa (eye worm) | CMGC/CDK/CDK5 protein kinase | 0.0182 | 0.2626 | 0.2626 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.019 | 0.2803 | 0.2803 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0182 | 0.2626 | 0.2626 |
Trichomonas vaginalis | mercuric reductase, putative | 0.019 | 0.2803 | 0.9863 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0182 | 0.2626 | 0.9238 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0182 | 0.2626 | 0.2626 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0182 | 0.2626 | 0.2626 |
Brugia malayi | Thioredoxin reductase | 0.055 | 1 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.019 | 0.2803 | 1 |
Trypanosoma cruzi | cdc2-related kinase 3 | 0.0182 | 0.2626 | 0.2626 |
Loa Loa (eye worm) | AUR protein kinase | 0.0192 | 0.2842 | 0.2842 |
Treponema pallidum | NADH oxidase | 0.019 | 0.2803 | 1 |
Echinococcus granulosus | cyclin dependent kinase 1 | 0.0182 | 0.2626 | 0.2626 |
Trypanosoma cruzi | aurora B kinase, putative | 0.0192 | 0.2842 | 0.2842 |
Entamoeba histolytica | serine/threonine protein kinase 6, putative | 0.0192 | 0.2842 | 1 |
Trichomonas vaginalis | AGC family protein kinase | 0.0192 | 0.2842 | 1 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.019 | 0.2803 | 0.2803 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.019 | 0.2803 | 0.2803 |
Loa Loa (eye worm) | CMGC/CDK/CDC2 protein kinase | 0.0182 | 0.2626 | 0.2626 |
Brugia malayi | Protein kinase domain containing protein | 0.0182 | 0.2626 | 0.2626 |
Echinococcus multilocularis | cyclin dependent kinase | 0.0182 | 0.2626 | 0.2626 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.0213 | 0.0213 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.019 | 0.2803 | 0.2803 |
Plasmodium falciparum | glutathione reductase | 0.019 | 0.2803 | 0.2803 |
Loa Loa (eye worm) | AUR protein kinase | 0.0192 | 0.2842 | 0.2842 |
Brugia malayi | serine/threonine protein kinase 6 | 0.0192 | 0.2842 | 0.2842 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.019 | 0.2803 | 0.2803 |
Plasmodium falciparum | thioredoxin reductase | 0.019 | 0.2803 | 0.2803 |
Giardia lamblia | Kinase, CMGC CDK | 0.0182 | 0.2626 | 0.9238 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.019 | 0.2803 | 0.2803 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.019 | 0.2803 | 0.2803 |
Entamoeba histolytica | serine/threonine- protein kinase 6, putative | 0.0192 | 0.2842 | 1 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0061 | 0.0213 | 0.0213 |
Plasmodium vivax | glutathione reductase, putative | 0.055 | 1 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.019 | 0.2803 | 1 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.019 | 0.2803 | 0.2803 |
Trichomonas vaginalis | AGC family protein kinase | 0.0192 | 0.2842 | 1 |
Leishmania major | trypanothione reductase | 0.055 | 1 | 1 |
Brugia malayi | TAR-binding protein | 0.0061 | 0.0213 | 0.0213 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.019 | 0.2803 | 0.2803 |
Loa Loa (eye worm) | thioredoxin reductase | 0.055 | 1 | 1 |
Echinococcus granulosus | cyclin dependent kinase 5 | 0.0182 | 0.2626 | 0.2626 |
Leishmania major | protein kinase, putative | 0.0192 | 0.2842 | 0.2842 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.019 | 0.2803 | 1 |
Loa Loa (eye worm) | RNA binding protein | 0.0061 | 0.0213 | 0.0213 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.019 | 0.2803 | 0.2803 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.055 | 1 | 1 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.019 | 0.2803 | 0.2803 |
Toxoplasma gondii | cell-cycle-associated protein kinase CDK, putative | 0.0182 | 0.2626 | 0.2626 |
Brugia malayi | RNA binding protein | 0.0061 | 0.0213 | 0.0213 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.019 | 0.2803 | 1 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.019 | 0.2803 | 0.2803 |
Giardia lamblia | Aurora kinase | 0.0192 | 0.2842 | 1 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.019 | 0.2803 | 0.2803 |
Leishmania major | cell division protein kinase 2,cdc2-related kinase | 0.0182 | 0.2626 | 0.2626 |
Trypanosoma brucei | aurora B kinase | 0.0192 | 0.2842 | 0.2842 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.019 | 0.2803 | 1 |
Trypanosoma brucei | cdc2-related kinase 3 | 0.0182 | 0.2626 | 0.2626 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0182 | 0.2626 | 0.9238 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.019 | 0.2803 | 0.2803 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.019 | 0.2803 | 0.2803 |
Trichomonas vaginalis | AGC family protein kinase | 0.0192 | 0.2842 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.019 | 0.2803 | 0.2803 |
Echinococcus granulosus | tar DNA binding protein | 0.0061 | 0.0213 | 0.0213 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.019 | 0.2803 | 0.2803 |
Plasmodium falciparum | glutathione reductase | 0.055 | 1 | 1 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.019 | 0.2803 | 0.2803 |
Loa Loa (eye worm) | AUR protein kinase | 0.0192 | 0.2842 | 0.2842 |
Plasmodium falciparum | protein kinase 5 | 0.0182 | 0.2626 | 0.2626 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.0213 | 0.0213 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0192 | 0.2842 | 1 |
Echinococcus multilocularis | cyclin dependent kinase 5 | 0.0182 | 0.2626 | 0.2626 |
Entamoeba histolytica | protein kinase, putative | 0.0192 | 0.2842 | 1 |
Trypanosoma brucei | cdc2-related kinase 1 | 0.0182 | 0.2626 | 0.2626 |
Onchocerca volvulus | 0.0051 | 0 | 0.5 | |
Echinococcus multilocularis | serine:threonine protein kinase 12 B | 0.0192 | 0.2842 | 0.2842 |
Echinococcus multilocularis | aurora kinase A | 0.0192 | 0.2842 | 0.2842 |
Plasmodium vivax | thioredoxin reductase, putative | 0.055 | 1 | 1 |
Leishmania major | cell division related protein kinase 2,cdc2-related kinase | 0.0182 | 0.2626 | 0.2626 |
Echinococcus granulosus | cyclin dependent kinase | 0.0182 | 0.2626 | 0.2626 |
Brugia malayi | cell division control protein 2 homolog | 0.0182 | 0.2626 | 0.2626 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.019 | 0.2803 | 0.9863 |
Trichomonas vaginalis | AGC family protein kinase | 0.0192 | 0.2842 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.055 | 1 | 1 |
Entamoeba histolytica | serine/threonine- protein kinase 6 , putative | 0.0192 | 0.2842 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.055 | 1 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0061 | 0.0213 | 0.0213 |
Loa Loa (eye worm) | TAR-binding protein | 0.0061 | 0.0213 | 0.0213 |
Brugia malayi | serine/threonine-protein kinase 6 | 0.0192 | 0.2842 | 0.2842 |
Brugia malayi | serine/threonine kinase 12 | 0.0192 | 0.2842 | 0.2842 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.019 | 0.2803 | 0.2803 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0182 | 0.2626 | 0.2626 |
Trypanosoma cruzi | cdc2-related kinase 1 | 0.0182 | 0.2626 | 0.2626 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.019 | 0.2803 | 0.2803 |
Loa Loa (eye worm) | hypothetical protein | 0.0177 | 0.2536 | 0.2536 |
Echinococcus multilocularis | cyclin dependent kinase 1 | 0.0182 | 0.2626 | 0.2626 |
Plasmodium vivax | protein kinase Crk2 | 0.0182 | 0.2626 | 0.2626 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.0213 | 0.0213 |
Entamoeba histolytica | cell division protein kinase 2, putative | 0.0182 | 0.2626 | 0.9238 |
Giardia lamblia | Kinase, CMGC CDK | 0.0182 | 0.2626 | 0.9238 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.055 | 1 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0061 | 0.0213 | 0.0213 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.019 | 0.2803 | 0.2803 |
Toxoplasma gondii | aurora kinase | 0.0192 | 0.2842 | 0.2842 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.019 | 0.2803 | 0.2803 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.019 | 0.2803 | 0.2803 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.014 | 0.179 | 0.179 |
Echinococcus granulosus | aurora kinase A | 0.0192 | 0.2842 | 0.2842 |
Plasmodium vivax | serine/threonine protein kinase 6, putative | 0.0192 | 0.2842 | 0.2842 |
Plasmodium falciparum | serine/threonine protein kinase, putative | 0.0192 | 0.2842 | 0.2842 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.019 | 0.2803 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0192 | 0.2842 | 0.2842 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 19.48 % | Analgesic activity in Swiss mouse assessed as increase in reaction time at 20 mg/kg, po after 30 mins by Eddy's hot plate technique | ChEMBL. | 17331622 |
Activity (functional) | = 19.48 % | Analgesic activity in Swiss mouse assessed as increase in reaction time at 20 mg/kg, po after 30 mins by Eddy's hot plate technique | ChEMBL. | 17331622 |
Activity (functional) | = 28.54 % | Analgesic activity in Swiss mouse assessed as increase in reaction time at 20 mg/kg, po after 60 mins by Eddy's hot plate technique | ChEMBL. | 17331622 |
Activity (functional) | = 28.54 % | Analgesic activity in Swiss mouse assessed as increase in reaction time at 20 mg/kg, po after 60 mins by Eddy's hot plate technique | ChEMBL. | 17331622 |
Activity (functional) | = 35.24 % | Analgesic activity in Swiss mouse assessed as increase in reaction time at 20 mg/kg, po after 90 mins by Eddy's hot plate technique | ChEMBL. | 17331622 |
Activity (functional) | = 35.24 % | Analgesic activity in Swiss mouse assessed as increase in reaction time at 20 mg/kg, po after 90 mins by Eddy's hot plate technique | ChEMBL. | 17331622 |
Inhibition (functional) | = 11.32 % | Antiinflammatory activity in Wistar Albino rat assessed as inhibition of carrageenan-induced paw oedema at 20 mg/kg after 1 hr relative to control | ChEMBL. | 17331622 |
Inhibition (functional) | = 20.03 % | Antiinflammatory activity in Wistar Albino rat assessed as inhibition of carrageenan-induced paw oedema at 20 mg/kg after 2 hrs relative to control | ChEMBL. | 17331622 |
Inhibition (functional) | = 26.05 % | Antiinflammatory activity in Wistar Albino rat assessed as inhibition of carrageenan-induced paw oedema at 20 mg/kg after 3 hrs relative to control | ChEMBL. | 17331622 |
Inhibition (functional) | = 32.66 % | Antiinflammatory activity in Wistar Albino rat assessed as inhibition of carrageenan-induced paw oedema at 20 mg/kg after 4 hrs relative to control | ChEMBL. | 17331622 |
IZ (functional) | = 4.12 mm | Antibacterial activity against Bacillus subtilis at 10 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 4.15 mm | Antibacterial activity against Pseudomonas aeruginosa at 10 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 4.17 mm | Antibacterial activity against Staphylococcus aureus at 10 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 4.26 mm | Antibacterial activity against Escherichia coli at 10 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 4.26 mm | Antibacterial activity against Escherichia coli at 10 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 4.35 mm | Antifungal activity against Candida albicans at 10 ug/ml by paper disc method | ChEMBL. | 17331622 |
IZ (functional) | = 4.35 mm | Antifungal activity against Candida albicans at 10 ug/ml by paper disc method | ChEMBL. | 17331622 |
IZ (functional) | = 4.56 mm | Antifungal activity against Aspergillus niger at 10 ug/ml by paper disc method | ChEMBL. | 17331622 |
IZ (functional) | = 7.18 mm | Antibacterial activity against Bacillus subtilis at 20 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 7.28 mm | Antibacterial activity against Escherichia coli at 20 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 7.28 mm | Antibacterial activity against Escherichia coli at 20 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 7.92 mm | Antibacterial activity against Pseudomonas aeruginosa at 20 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 8.12 mm | Antibacterial activity against Staphylococcus aureus at 20 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 8.24 mm | Antifungal activity against Aspergillus niger at 20 ug/ml by paper disc method | ChEMBL. | 17331622 |
IZ (functional) | = 8.72 mm | Antifungal activity against Candida albicans at 20 ug/ml by paper disc method | ChEMBL. | 17331622 |
IZ (functional) | = 8.72 mm | Antifungal activity against Candida albicans at 20 ug/ml by paper disc method | ChEMBL. | 17331622 |
IZ (functional) | = 11.72 mm | Antifungal activity against Candida albicans at 30 ug/ml by paper disc method | ChEMBL. | 17331622 |
IZ (functional) | = 11.72 mm | Antifungal activity against Candida albicans at 30 ug/ml by paper disc method | ChEMBL. | 17331622 |
IZ (functional) | = 11.91 mm | Antibacterial activity against Bacillus subtilis at 30 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 12.12 mm | Antibacterial activity against Staphylococcus aureus at 30 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 12.26 mm | Antifungal activity against Aspergillus niger at 30 ug/ml by paper disc method | ChEMBL. | 17331622 |
IZ (functional) | = 12.28 mm | Antibacterial activity against Escherichia coli at 30 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 12.28 mm | Antibacterial activity against Escherichia coli at 30 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
IZ (functional) | = 12.37 mm | Antibacterial activity against Pseudomonas aeruginosa at 30 ug/ml by agar plate diffusion technique | ChEMBL. | 17331622 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.